Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CADL Candel Therapeutics, Inc.

Market Closed 02-27 16:00:00 EST

5.25

+0.10

+1.94%

盘后5.30

+0.05+0.95%

19:58 EST

High5.54	Low5.20	Vol2.10M
Open5.54	D1 Closing5.15	Amplitude6.60%
Mkt Cap384.53M	Tradable Cap238.76M	Total Shares73.24M
T/O11.23M	T/O Rate4.62%	Tradable Shares45.48M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CADL","market":"US","secType":"STK","nameCN":"Candel Therapeutics, Inc.","latestPrice":5.25,"timestamp":1772226000000,"preClose":5.15,"halted":0,"volume":2102742,"hourTrading":{"tag":"盘后","latestPrice":5.3,"preClose":5.25,"latestTime":"19:58 EST","volume":19206,"amount":100916.7597,"timestamp":1772240300339,"change":0.05,"changeRate":0.009524,"amplitude":0.011429},"delay":0,"changeRate":0.01941747572815527,"floatShares":45478500,"shares":73244500,"eps":-0.56,"marketStatus":"Market Closed","change":0.1,"latestTime":"02-27 16:00:00 EST","open":5.54,"high":5.54,"low":5.2,"amount":11230336.038681,"amplitude":0.066019,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.56,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"adr":0,"listingDate":1627358400000,"exchange":"NASDAQ","adjPreClose":5.15,"preHourTrading":{"tag":"盘前","latestPrice":5.54,"preClose":5.15,"latestTime":"09:29 EST","volume":125457,"amount":692413.4045901,"timestamp":1772202599952,"change":0.39,"changeRate":0.075728,"amplitude":0.081553},"postHourTrading":{"tag":"盘后","latestPrice":5.3,"preClose":5.25,"latestTime":"19:58 EST","volume":19206,"amount":100916.7597,"timestamp":1772240300339,"change":0.05,"changeRate":0.009524,"amplitude":0.011429},"volumeRatio":0.68545,"impliedVol":1.2575,"impliedVolPercentile":0.6215},"requestUrl":"/m/hq/s/CADL/tweets","defaultTab":"tweets","newsList":[{"id":"2614100301","title":"Candel Therapeutics Director Paul B. Manning Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2614100301","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614100301?lang=en_us&edition=fundamental","pubTime":"2026-02-27 08:39","pubTimestamp":1772152770,"startTime":"0","endTime":"0","summary":"Paul B. Manning, a director of Candel Therapeutics, Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nNDL47b4rV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Candel Therapeutics Director Paul B. Manning Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2613371124","title":"Candel Therapeutics CEO Paul Peter Tak to Present at TD Cowen’s 46th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2613371124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613371124?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:05","pubTimestamp":1771938330,"startTime":"0","endTime":"0","summary":"Candel Therapeutics CEO Paul Peter Tak to Present at TD Cowen’s 46th Annual Health Care Conference               Candel Therapeutics Inc. said its President and CEO Paul Peter Tak will present at TD C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL7xq2h1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","CADL","LU2095319765.USD","BK4112","LU2210150020.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4539","BK4588","IE00BKPKM429.USD","SG9999014013.SGD","BK4139","IE00B64PRP62.GBP","SG9999014021.USD","SG9999014005.SGD","BK4585","IE00BGHQF748.EUR","NDAQ","LU0314104364.USD"],"gpt_icon":0},{"id":"2613734787","title":"Candel Therapeutics Announces Equity Offering to Fund CAN-2409","url":"https://stock-news.laohu8.com/highlight/detail?id=2613734787","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613734787?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:56","pubTimestamp":1771854993,"startTime":"0","endTime":"0","summary":"Candel Therapeutics ( ($CADL) ) has shared an announcement. On February 19, 2026, Candel Therapeutics, Inc. entered into an underwriting agreement ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-announces-equity-offering-to-fund-can-2409?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-announces-equity-offering-to-fund-can-2409?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4600","BK4595","CADL","BK4585","BK4539","BK4170","BK4139","BK4588","BK4526","BK4215"],"gpt_icon":0},{"id":"2613184072","title":"BRIEF-Candel Therapeutics Files For Offering Of 18.3 Mln Shares Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2613184072","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613184072?lang=en_us&edition=fundamental","pubTime":"2026-02-21 06:47","pubTimestamp":1771627674,"startTime":"0","endTime":"0","summary":"BRIEF-Candel Therapeutics Files For Offering Of 18.3 Mln Shares Of Common StockFeb 20  - Candel Therapeutics Inc CADL.O:CANDEL THERAPEUTICS INC - FILES FOR OFFERING OF 18.3 MILLION SHARES OF COMMON STOCK - SEC FILINGSource text: [ID:n0001193125-26-061389]Further company coverage: CADL.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nFWN3ZG0Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CADL","BK4139"],"gpt_icon":0},{"id":"2613297614","title":"Candel Therapeutics Inc - Files for Offering of 18.3 Mln Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2613297614","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613297614?lang=en_us&edition=fundamental","pubTime":"2026-02-21 05:19","pubTimestamp":1771622390,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nFWN3ZG0Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CADL","BK4139"],"gpt_icon":0},{"id":"2613129118","title":"BUZZ-U.S. STOCKS ON THE MOVE-Homebuilders, solar stocks, Alphabet","url":"https://stock-news.laohu8.com/highlight/detail?id=2613129118","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613129118?lang=en_us&edition=fundamental","pubTime":"2026-02-21 02:42","pubTimestamp":1771612970,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Homebuilders, solar stocks, AlphabetEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nL6N3ZG0K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYB","POOL","GOOP","PPL","LU2360108059.USD","GPI","OWL","PAY","PHM","GOOY","WTTR","DECK","LU0640476718.USD","OPEX","ABG","CARS","CPRT","TGT","DHI","GRAL","LU2326559502.SGD","PAG","IE00BJLML261.HKD","GOOX","IE0002270589.USD","WU","AKAM","BK4579","GOOW","LU1815333072.USD","CADL","WH","UAA","GGLS","FIX","KBH","BLDR","CDT","BK4116","NVR","LU2360106780.USD","GOU","FNKO","LOW","OPEG","BK4155"],"gpt_icon":1},{"id":"2612267777","title":"BUZZ-U.S. STOCKS ON THE MOVE-Deckers Outdoor, CDT Equity, Comfort Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2612267777","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612267777?lang=en_us&edition=fundamental","pubTime":"2026-02-20 22:07","pubTimestamp":1771596474,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Deckers Outdoor, CDT Equity, Comfort SystemsEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nL6N3ZG0PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYB","OWL","WH","CDT","BK4179","BK4585","IE00BLSP4452.SGD","AKAM","WU","LU0787776722.HKD","IE00BLSP4239.USD","GRAL","BK4121","BK4567","BK4608","IE0031619046.USD","LU0208291251.USD","LU0683600562.USD","BK4142","PPL","CADL","BK4146","BK4106","IE00BBT3K403.USD","LU0266013472.USD","BK4139","BK4227","BK4081","IE00BD4GTV84.USD","IE00B19Z4B17.USD","BK4116","IE00BN8TJ469.HKD","BK4090","LU1093756325.SGD","DECK","IE00BD4GTT62.SGD","IE00BD4GTW91.USD","BK4129","FIX","IE00B66KJ199.SGD","BK4559","WTTR","BK4554","LU0963586101.USD","IE00B7SZL793.SGD","BK4588","BK4539","LU2286300806.USD","LU1093756168.USD","POOL"],"gpt_icon":0},{"id":"2612261946","title":"BUZZ-U.S. STOCKS ON THE MOVE-Akamai, Grail, Candel Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2612261946","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612261946?lang=en_us&edition=fundamental","pubTime":"2026-02-20 20:06","pubTimestamp":1771589210,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Akamai, Grail, Candel TherapeuticsEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nL6N3ZG0ML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1059921491.USD","WTTR","BK4179","CADL","GRAL","BK4585","BK4539","BK4554","BK4608","IE00B66KJ199.SGD","IE00B7SZL793.SGD","LU2286300806.USD","BK4116","BK4588","IE0031619046.USD","IE00B19Z4B17.USD","AKAM"],"gpt_icon":0},{"id":"2612526135","title":"Shares of Candel Therapeutics Down 12.8% Premarket After Pricing $100 Mln Equity Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612526135","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612526135?lang=en_us&edition=fundamental","pubTime":"2026-02-20 20:00","pubTimestamp":1771588836,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nL4N3ZG0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","CADL","BK4139"],"gpt_icon":0},{"id":"2612266934","title":"Why Is Candel Therapeutics Stock Falling Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2612266934","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612266934?lang=en_us&edition=fundamental","pubTime":"2026-02-20 18:55","pubTimestamp":1771584900,"startTime":"0","endTime":"0","summary":"Candel Therapeutics stock down on public offering pricing, intends to use proceeds for cancer therapies and development costs.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/20/Tumor-Microenvironment-Concept-With-Canc.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/20/Tumor-Microenvironment-Concept-With-Canc.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/offerings/26/02/50743727/why-is-candel-therapeutics-stock-falling-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/offerings/26/02/50743727/why-is-candel-therapeutics-stock-falling-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["CADL","BK4225","HR","BK4539","SMA","BK4217","BK4203","BK4139"],"gpt_icon":0},{"id":"2612051258","title":"Candel Therapeutics Announces Pricing Of Public Offering Of 18,348,624 Shares At $5.45 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2612051258","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612051258?lang=en_us&edition=fundamental","pubTime":"2026-02-20 10:53","pubTimestamp":1771555984,"startTime":"0","endTime":"0","summary":"Feb 19 (Reuters) - Candel Therapeutics Inc ::*CANDEL THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING*CANDEL THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 18,348,624 SHARES AT $5.45 EACH  ((Reuters In","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nRSD6mndZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2612258413","title":"Candel Therapeutics Inc - Prices Public Offering of 18,348,624 Shares at $5.45 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2612258413","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612258413?lang=en_us&edition=fundamental","pubTime":"2026-02-20 10:40","pubTimestamp":1771555200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nTUA39DKYD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2612236913","title":"Candel Therapeutics Secures $100M Royalty Funding for CAN-2409","url":"https://stock-news.laohu8.com/highlight/detail?id=2612236913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612236913?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:53","pubTimestamp":1771537991,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Candel Therapeutics ( ($CADL) ). On February 19, 2026, Candel Therapeutics announced a $100 million royalty-bas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-secures-100m-royalty-funding-for-can-2409?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/candel-therapeutics-secures-100m-royalty-funding-for-can-2409?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4170","CADL","BK4595","BK4526","BK4600","BK4139","BK4539"],"gpt_icon":0},{"id":"2612235282","title":"BRIEF-Candel Therapeutics Announces Proposed $100 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612235282","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612235282?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:42","pubTimestamp":1771537330,"startTime":"0","endTime":"0","summary":"BRIEF-Candel Therapeutics Announces Proposed $100 Million Public OfferingCandel Therapeutics Inc CADL.O:CANDEL THERAPEUTICS ANNOUNCES PROPOSED $100 MILLION PUBLIC OFFERINGCANDEL THERAPEUTICS INC - PRO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUA7HVDDJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2612323537","title":"BUZZ-Candel Therapeutics falls after announcing $100 mln stock offering, royalty agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2612323537","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612323537?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:31","pubTimestamp":1771536719,"startTime":"0","endTime":"0","summary":"BUZZ-Candel Therapeutics falls after announcing $100 mln stock offering, royalty agreement** Candel Therapeutics CADL.O shares down 6.6% to $5.56 post-market as it seeks equity and announces royalty agreement** Needham, Massachusetts-based firm launches $100 mln stock offering** Co intends to use net offering proceeds to complete launch readiness, along with commercial activities for CAN-2409, or aglatimagene, to treat prostate cancer, and ongoing development costs related to Phase 3 trial of aglatimagene in non-small cell lung cancer, among other purposes** CADL also announces a $100 mln royalty funding agreement with funds managed by RTW Investments, subject to US FDA approval of aglatimagene** Citigroup, Cantor and Stifel joint bookrunners for stock offering** With ~54.9 mln shares outstanding, CADL has about $325 mln market cap** Stock on Thurs ended up 1.7% at $5.95, up 35% over the past three months** Avg rating of 8 analysts is \"buy\"; median PT $19.50, per LSEG data","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nL6N3ZF15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU0314106906.USD","LU1201861249.SGD","LU1244550577.SGD","LU1162221912.USD","LU0477156953.USD","LU0162691827.USD","LU0170899867.USD","LU1244550494.USD","LU1668664300.SGD","LU2236285917.USD","BK4585","BK4588","LU0128525689.USD","LU0310800965.SGD","LU2125154935.USD","LU2360032135.SGD","LU1366192091.USD","LU1506573853.SGD","LU0980610538.SGD","LU0648001328.SGD","CADL","LU0052756011.USD","LU1244550221.USD","LU0072461881.USD","LU1267930227.SGD","LU1791807156.HKD","BK4566","BK4539","BK4534","LU2125154778.USD","BK4207","LU0130102774.USD","LU0106831901.USD","IE00BSNM7G36.USD","BK4504","BK4139","LU2417539215.USD","LU0098860793.USD","LU0320765646.SGD","LU2456880835.USD","LU2462157665.USD","LU0130517989.USD"],"gpt_icon":0},{"id":"2612332172","title":"Candel Therapeutics announces $100M common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2612332172","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612332172?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:13","pubTimestamp":1771535622,"startTime":"0","endTime":"0","summary":"Candel Therapeutics (CADL) announced the launch of an underwritten public offering of $100M of its common stock. All shares of common stock to be s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-announces-100m-common-stock-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/candel-therapeutics-announces-100m-common-stock-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","CADL"],"gpt_icon":0},{"id":"2612238986","title":"Candel Therapeutics Inc - Proceeds to Fund Aglatimagene Launch and Phase 3 Trial Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2612238986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612238986?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:05","pubTimestamp":1771535105,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUA7HVDDJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2612223881","title":"Candel Therapeutics Secures $100M Royalty Funding Agreement With RTW Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2612223881","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612223881?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:01","pubTimestamp":1771534881,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Inc. entered a $100 million royalty funding agreement with funds managed by RTW Investments, LP to support a potential U.S. launch of its prostate cancer therapy CAN-2409. The non-dilutive funding becomes available upon FDA approval and other customary conditions, and RTW will receive a capped, tiered single-digit royalty on annual U.S. net sales of the product.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL40R3vb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","SG9999014005.SGD","SG9999014013.SGD","IE00B64PRP62.GBP","BK4585","LU2095319765.USD","BK4539","IE00BGHQF748.EUR","CADL","IE00BKPKM429.USD","BK4139","IE00B3QW5Z07.USD","BK4588","NDAQ","BK4112","SG9999014021.USD","LU2210149790.SGD","SG9999014039.USD"],"gpt_icon":0},{"id":"2612023880","title":"Candel Therapeutics: Under Agreement, Rtw Will Receive a Tiered Single Digit Percentage of Annual Net Sales of Aglatimagene in U.S. Subject to a Cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2612023880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612023880?lang=en_us&edition=fundamental","pubTime":"2026-02-20 05:01","pubTimestamp":1771534860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nTUABHVG3Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CADL","BK4539"],"gpt_icon":0},{"id":"2610540930","title":"Candel Therapeutics Showcases Glioblastoma Immunotherapy Advances at Drug Development Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2610540930","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610540930?lang=en_us&edition=fundamental","pubTime":"2026-02-11 21:06","pubTimestamp":1770815207,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies for cancer, will participate in the 7th Annual Glioblastoma Drug Development Summit from February 17-19, 2026, in Boston, Massachusetts. Dr. Francesca Barone, Candel's Chief Scientific Officer, will present data and insights from the company's HSV-based platform and the linoserpaturev  program targeting recurrent high-grade glioma. Dr. Barone will be involved in several sessions, including a workshop panel on patient stratification using omics data , a conference presentation on integrating biomarkers and imaging in a Phase I/II clinical trial , and a panel discussion on biomarker-based enrollment in GBM trials . Links to event-related documents and materials: - PDF Version. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDLc5ckyK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CADL","BK4139","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.candeltx.com","stockEarnings":[{"period":"1week","weight":0.0284},{"period":"1month","weight":-0.0854},{"period":"3month","weight":0.1006},{"period":"6month","weight":-0.0933},{"period":"1year","weight":-0.3895},{"period":"ytd","weight":-0.0708}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent high-grade glioma. It also develops the?enLIGHTEN Discovery Platform, a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.056687},{"month":2,"riseRate":0.4,"avgChangeRate":0.052018},{"month":3,"riseRate":0.25,"avgChangeRate":-0.133894},{"month":4,"riseRate":0.25,"avgChangeRate":0.747487},{"month":5,"riseRate":1,"avgChangeRate":0.149002},{"month":6,"riseRate":0,"avgChangeRate":-0.170269},{"month":7,"riseRate":0.25,"avgChangeRate":0.011025},{"month":8,"riseRate":0.8,"avgChangeRate":0.068985},{"month":9,"riseRate":0.4,"avgChangeRate":-0.01705},{"month":10,"riseRate":0.4,"avgChangeRate":-0.110246},{"month":11,"riseRate":0,"avgChangeRate":-0.079739},{"month":12,"riseRate":0.8,"avgChangeRate":0.288433}],"exchange":"NASDAQ","name":"Candel Therapeutics, Inc.","nameEN":"Candel Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Candel Therapeutics, Inc.(CADL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Candel Therapeutics, Inc.,CADL,Candel Therapeutics, Inc.股票,Candel Therapeutics, Inc.股票老虎,Candel Therapeutics, Inc.股票老虎国际,Candel Therapeutics, Inc.行情,Candel Therapeutics, Inc.股票行情,Candel Therapeutics, Inc.股价,Candel Therapeutics, Inc.股市,Candel Therapeutics, Inc.股票价格,Candel Therapeutics, Inc.股票交易,Candel Therapeutics, Inc.股票购买,Candel Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Candel Therapeutics, Inc.(CADL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Candel Therapeutics, Inc.(CADL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}